IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q3 2016 Holdings

Filed 2016-11-14 | 2 holdings | $1.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Onconova Therapeutics IncCOM NEW68232V306$1.5K520,83278.8%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$391390,62421.2%